Browsing by Author Dore, Gregory

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 27  next >
Issue DateTitleAuthor(s)Citation
2009Antiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screeningGeorge, Jacob; Howard, Kirsten; Robotin, Monica; Dore, Gregory; Kansil, Melanie; Levy, Miriam; Penman, Andrew; Tipper, Steven; Western Clinical School: Westmead Millennium Institute; School of Public Health: Public Health; School of Public Health: Public HealthAntiviral therapy for hepatitis B-related liver cancer prevention is more cost-effective than cancer screening, Journal of Hepatology, vol.50, 5,pp 990-998
2014Assessing the feasibility of hepatitis C virus vaccine trials: Results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness studyWhite, Bethany; Dore, Gregory; Hellard, Margaret; Madden, Annie; Maher, Lisa; Page, Kimberly; Prins, Maria; Wand, Handan; Central Clinical School: Addiction MedicineAssessing the feasibility of hepatitis C virus vaccine trials: Results from the Hepatitis C Incidence and Transmission Study-community (HITS-c) vaccine preparedness study, Vaccine, vol.32, 42, 2014,pp 5460-5467
2010Chronic Hepatitis C is Associated with Peripheral rather than Hepatic Insulin Resistance.Fragomeli, Vincenzo; George, Jacob; van der Poorten, David; Weltman, Martin; Chisholm, Donald J; Dore, Gregory; Jenkins, Arthur; Milner, Kerry-Lee; Smythe, George A.; Trenell, Michael; Xu, Aimin; Zekry, Amany; Faculty of Nursing & Midwifery; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Nepean Clinical School: MedicineChronic Hepatitis C is Associated with Peripheral rather than Hepatic Insulin Resistance., Gastroenterology, vol.138, 3,pp 932-941
2009Clinical trial literacy among injecting drug users in Sydney, Australia: A pilot studyDay, Carolyn; Doab, A; Dore, Gregory; Maher, Lisa; Topp, Libby; Central Clinical School: Addiction MedicineClinical trial literacy among injecting drug users in Sydney, Australia: A pilot study, Contemporary Clinical Trials, vol.30, 5,pp 431-435
2014Distribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studiesBooth, David; George, Jacob; McCaughan, Geoffrey William; Bollipo, Steven; Cheng, Wendy; Crawford, Darrell; Dore, Gregory; Leung, Reynold; Mitchell, Joanne; Ostapowicz, George; Roberts, Stuart; Sievert, William; Sloss, Andrew; Thompson, Alexander; Weltman, Martin; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Centenary InstituteDistribution of interferon lambda-3 gene polymorphisms in Australian patients with previously untreated genotype 1 chronic hepatitis C: Analysis from the PREDICT and CHARIOT studies, Journal of Gastroenterology and Hepatology, vol.29, 1, 2014,pp 179-184
2012Effect of pegylated interferon alfa-2a treatment on mental health during recent hepatitis C virus infectionDay, Carolyn; Haber, Paul; Alavi, Maryam; Dore, Gregory; Grebely, Jason; Hellard, Margaret; Kaldor, John; Lloyd, Andrew; Matthews, Gail V; Petoumenos, Kathy; van Beek, I; Yeung, Barbara; Central Clinical School: Addiction Medicine; Central Clinical School: Addiction MedicineEffect of pegylated interferon alfa-2a treatment on mental health during recent hepatitis C virus infection, Journal of Gastroenterology and Hepatology, vol.27, 5, 2012,pp 957-965
2015The effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS studyDay, Carolyn; Haber, Paul; Alavi, Maryam; Balcomb, Annie C.; Bath, Nicky; Bruneau, Julie; Dore, Gregory; Dunlop, Adrian; Fortier, Emmanuel; Grebely, Jason; Micallef, Michelle; Treloar, Carla; Central Clinical School: Addiction Medicine; Central Clinical School: Addiction MedicineThe effect of social functioning and living arrangement on treatment intent, specialist assessment and treatment uptake for hepatitis C virus infection among people with a history of injecting drug use: The ETHOS study, International Journal of Drug Policy, vol.26, 11, 2015,pp 1094-1102
2010Effective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection.Haber, Paul; McCaughan, Geoffrey; Dore, Gregory; et al, various; Grebely, Jason; Hellard, Margaret; Marks, Phillipa; Matthews, G; Petoumenos, Kathy; van Beek, I; White, Peter A; Yeung, B; Central Clinical School: Addiction Medicine; Central Clinical School: Centenary InstituteEffective Treatment of Injecting Drug Users With Recently Acquired Hepatitis C Virus Infection., Gastroenterology, vol.138, 1,pp 123-135.e1-2
2015Evaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, AustraliaDay, Carolyn; Bath, Nicky; Dore, Gregory; Everingham, Hope; Grebely, Jason; Hazelwood, Sue; Micallef, Michelle; Rance, Jake; Treloar, Carla; Central Clinical School: Addiction MedicineEvaluation of two community-controlled peer support services for assessment and treatment of hepatitis C virus infection in opioid substitution treatment clinics: The ETHOS study, Australia, International Journal of Drug Policy, vol.26, 10, 2015,pp 992-998
2015Excluding people who use drugs or alcohol from access to hepatitis C treatments - Is this fair, given the available data?Macneill, Paul Ulhas; Bruggmann, Philip; Byrne, Jude; Dore, Gregory; Grebely, Jason; Haire, Bridget; Levin, Jules; Litwin, Alain; Swan, Tracy; Taylor, Lynn; School of Public Health: Ctr for Values Ethics & Law in MedExcluding people who use drugs or alcohol from access to hepatitis C treatments - Is this fair, given the available data?, Journal of Hepatology, vol.63, 4, 2015,pp 779-782
2016FibroGENE: A gene-based model for staging liver fibrosisAhlenstiel, Golo; Booth, David; Douglas, Mark; Eslam, Mohammed; George, Jacob; Kelaeng, Kebitsaone; Liddle, Christopher; Weltman, Martin; Abate, Maria; Adams, Leon Anton; Berg, Thomas; Chan, Henry Lik Yuen; Dore, Gregory; et al, Various; Hashem, Ahmed M; Irving, William; Mangia, Alessandra; Romero-Gomez, Manuel; Sheridan, David; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead); Nepean Clinical School: MedicineFibroGENE: A gene-based model for staging liver fibrosis, Journal of Hepatology, vol.64, 2, 2016,pp 390-398
2010Hepatitis B virus among injecting drug users in Sydney, Australia: prevalence, vaccination and knowledge of status.Day, Carolyn; Cunningham, Phillip; Dore, Gregory; Maher, Lisa; Rodgers, Craig; van Beek, I; White, B; Wodak, Alex D.; Central Clinical School: Addiction MedicineHepatitis B virus among injecting drug users in Sydney, Australia: prevalence, vaccination and knowledge of status., Drug and Alcohol Dependence, vol.108, 40210,pp 134-137
2006Hepatitis C in australia impact of a mass media campaign.Bauman, Adrian; Smith, Benjamin; Chen, Jack; Costello, Melanie; Dore, Gregory; Loveday, Stuart; Mackie, Brent; School of Public Health: Public Health; School of Public Health: Public HealthHepatitis C in australia impact of a mass media campaign., American Journal of Preventive Medicine, vol.31,(6),2006,pp 492-498
2004Hepatitis C Prevalence--A Nationwide Serosurvey.Burgess, Margaret; Gilbert, Gwendolyn; Amin, Janaki; Backhouse, J; Dore, Gregory; Gidding, Heather F.; Kaldor, John M.; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium InstituteHepatitis C Prevalence--A Nationwide Serosurvey., Communicable Diseases Intelligence, vol.28,(4),2004,pp 517-21-N/A
2017Hepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: Analysis of national sentinel surveillance dataO'Connor, Catherine Cecilia; Boettiger, David; Callander, Denton; Donovan, Basil; Dore, Gregory; Fairley, Christopher K.; Guy, Rebecca; Hellerd, Margaret; Law, Matthew; Matthews, Gail; School of Public Health: Public HealthHepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: Analysis of national sentinel surveillance data, BMC Infectious Diseases, vol.17, 1, 2017,pp 1-12
2012Hepatitis C treatment outcomes in Australian clinicsGeorge, Jacob; Haber, Paul; Amin, Janaki; Dore, Gregory; Gidding, Heather F.; Law, Matthew; Macdonald, Graeme A; Ostapowicz, George; Sasadeusz, J; Weltman, Martin; Western Clinical School: Westmead Millennium Institute; Central Clinical School: Addiction MedicineHepatitis C treatment outcomes in Australian clinics, Medical Journal of Australia, vol.196, 10, 2012,pp 633-637
2017Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regressionGeorge, Jacob; Amin, Janaki; Danta, Mark; Dore, Gregory; Grebely, Jason; Hajarizadeh, Behzad; Law, Matthew; Waziry, Reem; Westmead Clinical School: Westmead Institute for Medical ResHepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression, Journal of Hepatology, vol.67, 6, 2017,pp 1204-1212
2015Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver diseaseAhlenstiel, Golo; Booth, David; Douglas, Mark; Eslam, Mohammed; George, Jacob; Leung, Reynold; Liddle, Christopher; Weltman, Martin; Abate, Maria; Adams, Leon A.; Berg, Thomas; Chan, Henry L K; Dore, Gregory; et al, Various; Hashem, Ahmed M; Irving, William; Mangia, Alessandra; Romero-Gomez, Manuel; Sheridan, David; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Millennium Institute; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Nepean Clinical School: MedicineInterferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease, Nature Communications, vol.6, N/A, 2015,pp 1-10
2016MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis CAsimakopoulos, Anastasia; Douglas, Mark; Eslam, Mohammed; George, Jacob; Liddle, Christopher; Thabet, Khaled; van der Poorten, David; White, Rose; Berg, Thomas; Dore, Gregory; et al, Various; Gronbaek, Henning; Irving, William; Mangia, Alessandra; Romero-Gomez, Manuel; Sheridan, David; Shojaei, Maryam; Children's Hospital Westmead: Medicine; Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead); Western Clinical School: Westmead Institute for Medical Res; Western Clinical School: Medicine (Westmead); Children's Hospital Westmead: Medicine; Children's Hospital Westmead: Medicine; Central Clinical School: OfficeMBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C, Nature Communications, vol.7, N/A, 2016,pp 1-8
2013Plasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infectionGeorge, Jacob; Applegate, Tanya; Bruneau, Julie; Cherepanov, Vera; Dore, Gregory; Feld, Jordan; Grebely, Jason; Hellard, Margaret; Kaldor, John M; Lloyd, Andrew; Matthews, Gail; Petoumenos, Kathy; Shaw, Ineke; Sherker, Alana; Shoukry, Naglaa H.; Teutsch, Suzy; Yeung, Barbara; Zang, Geng; Western Clinical School: Westmead Millennium InstitutePlasma interferon-gamma-inducible protein-10 (IP-10) levels during acute hepatitis C virus infection, Hepatology, vol.57, 6, 2013,pp 2124-2134